EUVIMEDEUVIMED entdecken
Open Access

Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease

Rebiguli Aji, Yue Xu, Ziyi Wang, Wenxin Feng, Liming Gui, Hanyu Rao, Wei Zhang, Ningyuan Liu, Wei-Qiang Gao, Li Li

Theranostics · 2025

DOI: 10.7150/thno.105876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Rebiguli Aji und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School o…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Mesenchymal Stem Cells, Interleukin-10, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesMesenchymal Stem CellsInterleukin-10Mesenchymal Stem Cell TransplantationIntercellular Signaling Peptides and ProteinsHistone-Lysine N-MethyltransferaseAnimalsMiceDisease Models, AnimalDextran SulfateColitisMice, Inbred C57BLHumans

Stichwörter der Autor:innen

Grem1IL-10SETD2adipose-derived mesenchymal stem cellinflammatory bowel disease

Substanzen

Interleukin-10Intercellular Signaling Peptides and ProteinsDextran SulfateHistone-Lysine N-Methyltransferase

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, Chi…
  • School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China.

Zitieren

APA

Aji, R., Xu, Y., Wang, Z., Feng, W., Gui, L., Rao, H., Zhang, W., Liu, N., Gao, W. Q., & Li, L. (2025). Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease. Theranostics. https://doi.org/10.7150/thno.105876

Vancouver

Aji R, Xu Y, Wang Z, Feng W, Gui L, Rao H, et al. Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease. Theranostics. 2025. doi:10.7150/thno.105876

BibTeX
@article{Aji2025,
  author = {Aji, Rebiguli and Xu, Yue and Wang, Ziyi and Feng, Wenxin and Gui, Liming and Rao, Hanyu and Zhang, Wei and Liu, Ningyuan and Gao, Wei-Qiang and Li, Li},
  title = {Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.105876}
}
Kostenlos starten →